within Pharmacolibrary.Drugs.ATC.A;

model A07XA02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 15000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A07XA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Ceratonia, commonly known as carob, refers to preparations from the seeds or pods of Ceratonia siliqua. It has been used as a traditional antidiarrheal agent in adults and children, particularly in cases of mild to moderate diarrhea. Ceratonia is not a conventional pharmaceutical drug and is not assigned to widely recognized approved drug use today, but carob preparations are sometimes used in nutraceuticals and in food supplements.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic models or parameters for ceratonia/carob exist in the current biomedical literature, as its mechanism is largely local (adsorptive action in the gut) and systemic absorption is not significant.</p><h4>References</h4><ol><li><p>Xu, X, et al., &amp; Nel, AE (2023). Use of a Liver-Targeting Immune-Tolerogenic mRNA Lipid Nanoparticle Platform to Treat Peanut-Induced Anaphylaxis by Single- and Multiple-Epitope Nucleotide Sequence Delivery. <i>ACS nano</i> 17(5) 4942–4957. DOI:<a href=\"https://doi.org/10.1021/acsnano.2c12420\">10.1021/acsnano.2c12420</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36853930/\">https://pubmed.ncbi.nlm.nih.gov/36853930</a></p></li><li><p>Navarro, JA, et al., &amp; Fonseca, FR (2022). Pharmacokinetics and Endocrine Effects of an Oral Dose of D-Pinitol in Human Fasting Healthy Volunteers. <i>Nutrients</i> 14(19) –. DOI:<a href=\"https://doi.org/10.3390/nu14194094\">10.3390/nu14194094</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36235746/\">https://pubmed.ncbi.nlm.nih.gov/36235746</a></p></li><li><p>Tang, Y, et al., &amp; Wang, S (2023). Pharmacological Activities and Pharmacokinetics of Glycycoumarin. <i>Revista brasileira de farmacognosia : orgao oficial da Sociedade Brasileira de Farmacognosia</i> 33(3) 471–483. DOI:<a href=\"https://doi.org/10.1007/s43450-022-00342-x\">10.1007/s43450-022-00342-x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36567915/\">https://pubmed.ncbi.nlm.nih.gov/36567915</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A07XA02;
